The fourth quarter earnings season momentum continues this week, with results from Alphabet (GOOG, GOOGL), Amazon (AMZN), AMD (AMD), Qualcomm (QCOM), and Palantir (PLTR) highlighting the calendar. As of Jan. 30, 33% of S&P 500 (^GSPC) companies have reported fourth quarter results, according to FactSet data, and Wall Street analysts estimate an 11.9% increase in […]
Novo Nordisk A/S has cut the prices its weight-loss drug Wegovy by up to 37% in India, as the Danish drugmaker looks to hold its own against Eli Lilly & Co.’s Mounjaro in a country that’s home to the third largest obesity population in the world. Novo Nordisk will sell Poviztra 2.4 mg semaglutide injection […]
Cipla Ltd. has signed a deal with Eli Lilly & Co. India Pvt. Ltd. to market the blockbuster weight-loss drug Mounjaro under a new brand name—Yurpeak. Eli Lilly has partnered with Cipla to market its weight-loss drug Mounjaro as Yurpeak in India. (Representational Image/Adobe) As part of the agreement, the US-based drugmaker will manufacture and […]
Eli Lilly’s billion-dollar India investment plan includes contract manufacturing in the world’s third largest pharma market and a capability centre in Hyderabad Source link
